Skip to main content
OpenTrials

Clinical trial condition

Episodic Migraine

Explore clinical trials studying Episodic Migraine. Study availability and eligibility vary by location and protocol.

48 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Episodic Migraine trial results

Completed

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

NCT05207865

Conditions
Brain Diseases, Central Nervous System Diseases, Ear Diseases, +17 more
Locations
  • Elite Clinical Studies, LLC Phoenix, Arizona, United States
  • Advanced Investigative Medicine, Inc. Hawthorne, California, United States
  • Velocity Clinical Research - North Hollywood North Hollywood, California, United States
  • Chase Medical Research, LLC Waterbury, Connecticut, United States
View all 19 locations
View Trial Details
Completed

A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

NCT04437433

Conditions
Chronic Migraine, Episodic Migraine
Locations
  • Takanoko Hospital /ID# 232723 Matsuyama, Ehime, Japan
  • Fukuiken Saiseikai Hospital /ID# 232988 Fukui-shi, Fukui, Japan
  • Duplicate_Higashi Sapporo Neurology and Neurosurgery Clinic /ID# 232710 Sapporo, Hokkaido, Japan
  • Konan Medical Center /ID# 232922 Kobe, Hyōgo, Japan
View all 24 locations
View Trial Details
Completed

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

NCT05264129

Conditions
Episodic Migraine
Locations
  • Achieve Clinical Research, LLC /ID# 244912 Birmingham, Alabama, United States
  • Xenoscience, Inc /ID# 243506 Phoenix, Arizona, United States
  • Excell Research, Inc /ID# 242590 Oceanside, California, United States
  • Neurological Research Institute /ID# 244161 Santa Monica, California, United States
View all 37 locations
View Trial Details
Completed

A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine

NCT05127486

Conditions
Brain Diseases, Central Nervous System Diseases, Episodic Migraine, +5 more
Locations
  • Gilbert Neurology Gilbert, Arizona, United States
  • Foothills Research Center / CCT Research Phoenix, Arizona, United States
  • Alliance for Multispecialty Research, LLC Tempe Tempe, Arizona, United States
  • Velocity Clinical Research, Banning Banning, California, United States
View all 77 locations
View Trial Details
Completed

Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients

NCT03927144

Conditions
Brain Diseases, Central Nervous System Diseases, Disease Attributes, +12 more
Locations
  • Stanford Headache Center Stanford, California, United States
  • Yale Center for Clinical Research New Haven, Connecticut, United States
  • New England Institute for Neurology and Headache Stamford, Connecticut, United States
  • George Washington Hospital Washington D.C., District of Columbia, United States
View all 112 locations
View Trial Details

Related conditions